UBS Solactive China Technology UCITS ETF (BIT:CIT)
6.57
-0.02 (-0.27%)
Last updated: Apr 2, 2026, 10:09 AM CET
-3.25% (1Y)
| Assets | 217.57M |
| Expense Ratio | 0.47% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -3.53% |
| Volume | 1,166 |
| Open | 6.58 |
| Previous Close | 6.59 |
| Day's Range | 6.57 - 6.59 |
| 52-Week Low | 5.37 |
| 52-Week High | 8.76 |
| Beta | n/a |
| Holdings | 106 |
| Inception Date | Mar 5, 2021 |
About CIT
UBS Solactive China Technology UCITS ETF is headquartered in London, Greater London, United Kingdom.
Asset Class Equity
Category Information Technology
Region Asia Emerging
Stock Exchange Borsa Italiana
Ticker Symbol CIT
Provider UBS
Index Tracked Solactive China Technology Index
Performance
CIT had a total return of -3.53% in the past year, including dividends. Since the fund's inception, the average annual return has been -9.66%.
Top 10 Holdings
70.03% of assets| Name | Symbol | Weight |
|---|---|---|
| Yuan Renminbi Offshore | n/a | 11.52% |
| Alibaba Group Holding Limited | 9988 | 9.88% |
| Xiaomi Corporation | 1810 | 9.53% |
| Tencent Holdings Limited | 0700 | 9.05% |
| Meituan | 3690 | 8.75% |
| BYD Co Ltd Class H | BY6.DE | 7.04% |
| NetEase, Inc. | 9999 | 5.52% |
| Baidu, Inc. | BAIDF | 4.33% |
| Innovent Biologics, Inc. | 1801 | 2.27% |
| WuXi Biologics (Cayman) Inc. | 2269 | 2.15% |